Qlife Holding

Qlife Holding AB: Update on the reverse takeover process - "Red Chip" structure will not be approved by Nasdaq - other structures are pursued

Källa: MFN
Negativ

Sammanfattning

Nasdaq har meddelat att Qlife Holding AB inte kommer att godkännas för fortsatt notering om den planerade omvända fusionen genomförs med en Red Chip-struktur. Bolaget arbetar nu med alternativa strukturer för att slutföra transaktionen.

Analys

Beskedet från Nasdaq innebär ett hinder för den planerade omvända fusionen med Hipro Biotechnology Co., Ltd. "Red Chip"-strukturen uppfyller inte börsens krav för fortsatt notering. Bolaget söker nu alternativa lösningar, men osäkerhet kring transaktionens genomförande kvarstår. Trots detta kvarstår övertygelsen om att transaktionen skapar aktieägarvärde genom synergier.

Insikter

  • • Den planerade omvända fusionen stöter på regulatoriska hinder från Nasdaq.
  • • Bolaget söker aktivt alternativa strukturer för att genomföra transaktionen.
  • • Osäkerhet kring transaktionens slutförande kvarstår.
Påverkan · Negativ · 4/10
Liten påverkan
NegativNeutralPositiv
−100+10

Qlife Holding AB ("Qlife" or "the Company") and Hipro Biotechnology Co., Ltd.

("Hipro") are working on the planned reverse takeover, as announced in press

releases on 5 June 2025 and 5 October 2025. Hipro is currently working on

obtaining the required shareholder approvals to be able to carry out the reverse

takeover. The companies' legal advisors in China have recommended a transaction

structure for the reverse takeover called a "Red Chip" structure, which means

that Qlife is to acquire Hipro through overseas entities.

Nasdaq Stockholm AB ("Nasdaq") has now informed that the Company will not be

approved for continued listing if the Company carries out the "Red Chip"

structure. The reason for this is that such structure does not meet Nasdaq's

requirements for listing at Nasdaq First North and that in order for Nasdaq to

approve it, they would likely need to consider certain changes to their rules

and processes.

Qlife Holding AB ("Qlife" or "the Company") and Hipro Biotechnology Co., Ltd. ("Hipro") are working on the planned reverse takeover, as announced in press releases on 5 June 2025 and 5 October 2025. Hipro is currently working on obtaining the required shareholder approvals to be able to carry out the reverse takeover. The companies' legal advisors in China have recommended a transaction structure for the reverse takeover called a "Red Chip" structure, which means that Qlife is to acquire Hipro through overseas entities.

Nasdaq Stockholm AB ("Nasdaq") has now informed that the Company will not be approved for continued listing if the Company carries out the "Red Chip" structure. The reason for this is that such structure does not meet Nasdaq's requirements for listing at Nasdaq First North and that in order for Nasdaq to approve it, they would likely need to consider certain changes to their rules and processes.

Qlife remains fully committed to completing the transaction and is currently pursuing alternative structures with Hipro and its advisors in order to complete the transaction as announced. Qlife and Hipro continue to work closely together in their operations and are strongly convinced that the intended transaction will create significant shareholder value, driven by the operational and strategic synergies between the companies. Qlife is dedicated to maintaining transparency and working constructively with Nasdaq to identify a compliant and sustainable solution.

Further information about the intended terms of the transaction can be found in the press releases published on 5 June and 5 October 2025: "Qlife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover" and "Qlife Holding AB: The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended".

Further updates will be communicated as the process advances.

For more information please contact:

Thomas Warthoe, CEOtw@egoo.health+45 21 63 35 34

Fler nyheter från Qlife Holding

Relaterade pressmeddelanden och bolagshändelser från samma bolag.

Se bolagssidan
Qlife Holding: Qlife Holding AB: Update on the reverse takeover process - "Red Chip" structure will not be approved by Nasdaq - other structures are pursued - pressmeddelande och analys | Tickr